Beverly Ingram is a highly experienced regulatory professional with over 18 years in the pharmaceutical industry. Currently serving as the Global Portfolio Lead at Pfizer, Beverly leads a regulatory team focused on a diverse portfolio of biosimilar products. Previously, Beverly held key roles at GlaxoSmithKline and AstraZeneca, where responsibilities included managing teams for CMC dossier authoring and providing global CMC support for marketed products. Beverly earned a PhD in Biotechnology with a specialization in cell culture from The University of Manchester.
This person is not in the org chart
This person is not in any teams
This person is not in any offices